| Gene symbol | CD4 | Synonyms | CD4mut, IMD79, Leu-3, OKT4D, T4 | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.31 | dbXrefs | |
| Description | CD4 molecule | ||||
| GTO ID | GTC2567 |
| Trial ID | NCT04712864 |
| Disease | Cutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma |
| Altered gene | CD4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LB1901 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma |
| Year | 2021 |
| Country | United States |
| Company sponsor | Legend Biotech USA Inc |
| Other ID(s) | LB1901-TCL-1001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||